verified
SJR 0,785 · Q2
•
database
Scopus / SJR indexed
United States · Impact Journals LLC
workspace_premium
Q2 — Oncology
lock_open
Open Access
Oncotarget
Oncotarget is a journal indexed in SJR in Oncology with an H index of 192. It has an SJR impact factor of 0,785 and it has a best quartile of Q2. It has an SJR impact factor of 0,785.
Oncotarget focuses its scope in these topics and keywords: cancer, cell, cells, breast, human, tumor, expression, inhibition, protein, lung, ...
Publisher: Impact Journals LLC
Category: Oncology
Indexation:
verifiedScopus / SJR
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
0,785
Q2
H-index
192
Acceptance rate
pie_chart
22%
Selective
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
NPD
Open Access
Non-OA path
NPD
Metrics
Scimago and CountryOfPapers database fields
Scopus / SJR
SJR Impact
0,785
H-index
192
Docs (year)
112
Docs 3y
533
Total refs
3197
Cites 3y
1007
Citable 3y
449
Cites/Doc 2y
1.62
Ref/Doc
28.54
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.